SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001867096-22-000090
Filing Date
2022-06-09
Accepted
2022-06-09 17:13:38
Documents
2
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165480920373949.html 4  
1 FORM 4 wf-form4_165480920373949.xml 4 5757
2 JOHNSON, JOHN H POA ex-24.htm EX-24 2998
  Complete submission text file 0001867096-22-000090.txt   10212
Mailing Address DENDREON CORPORATION 1301 2ND AVENUE SEATTLE WA 98101
Business Address
JOHNSON JOHN (Reporting) CIK: 0001410781 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40880 | Film No.: 221006873

Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Issuer) CIK: 0001867096 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations